Yong Ben insider trades
Open-market stock purchases and sales by Yong Ben, Chief Med & Dev Officer at BridgeBio Oncology Therapeutics, Inc, from SEC Form 4 filings since Mar 6, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Sold (not open market) | $4.1K |
| Sep 14, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc | Sold | $15.7K |
| Jul 1, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Sold (not open market) | $8.2K |
| May 19, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc | Bought (not open market) | — |
| May 19, 2026 | CRBP Corbus Pharmaceuticals Holdings, Inc | Bought (not open market) | — |
| Apr 1, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Sold (not open market) | $9.5K |
| Mar 10, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Bought (not open market) | — |
| Mar 10, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Bought (not open market) | — |